Matches in SemOpenAlex for { <https://semopenalex.org/work/W1784018576> ?p ?o ?g. }
- W1784018576 endingPage "322" @default.
- W1784018576 startingPage "315" @default.
- W1784018576 abstract "Parkinson's disease (PD) is a common neurodegenerative disease. While its cause remains elusive, much progress has been made regarding its treatment. Available drugs have a good symptomatic effect, but none has yet been shown to slow the progression of the disease in humans. The most efficacious drug is levodopa, but it remains unclear whether the symptomatic benefit is associated with neurotoxic effects and long-term deterioration. The long-term problem associated with levodopa is the appearance of dyskinesias, which is significantly delayed among patients treated with dopamine agonists as initial therapy. Less clear is the role of other drugs in PD, such as monoamine oxidase inhibitors (MAOIs), including selegiline and rasagiline, the putative N-meihyl-o-aspartaie (NMDA) receptor antagonists amantadine and memantine, and the muscarinic receptor blockers. All these may be used as initial therapy and delay the use of dopaminergic drugs, or can be added later to reduce specific symptoms (tremor or dyskinesias). Advanced PD is frequently associated with cognitive decline. To some extent, this can be helped by treatment with cholinesterase inhibitors such as rivastigmine. Similarly, hallucinations and delusions affect PD patients in the advanced stages of their disease. The use of classical neuroleptic drugs in these patients is contraindicated because of their extrapyramidal effects, but atypical drugs, and particularly clozapine, are very helpful. The big void in the therapy of PD lies in the more advanced stages. Several motor symptoms, like postural instability, dysphagia, and dysphonia, as well as dyskinesias, are poorly controlled by existing drugs. New therapies should also be developed against autonomic symptoms, particularly constipation." @default.
- W1784018576 created "2016-06-24" @default.
- W1784018576 creator A5007494860 @default.
- W1784018576 date "2004-09-30" @default.
- W1784018576 modified "2023-09-30" @default.
- W1784018576 title "Drug treatment of Parkinson's disease" @default.
- W1784018576 cites W175054133 @default.
- W1784018576 cites W1969642675 @default.
- W1784018576 cites W1970616575 @default.
- W1784018576 cites W1971579987 @default.
- W1784018576 cites W1976813386 @default.
- W1784018576 cites W1985047864 @default.
- W1784018576 cites W1986051929 @default.
- W1784018576 cites W2007037518 @default.
- W1784018576 cites W2009005775 @default.
- W1784018576 cites W2013195910 @default.
- W1784018576 cites W2018047970 @default.
- W1784018576 cites W2018532706 @default.
- W1784018576 cites W2022487592 @default.
- W1784018576 cites W2027325559 @default.
- W1784018576 cites W2046191363 @default.
- W1784018576 cites W2047032017 @default.
- W1784018576 cites W2052236229 @default.
- W1784018576 cites W2056198101 @default.
- W1784018576 cites W2057491667 @default.
- W1784018576 cites W2058645605 @default.
- W1784018576 cites W2069962655 @default.
- W1784018576 cites W2076281963 @default.
- W1784018576 cites W2088319729 @default.
- W1784018576 cites W2097466872 @default.
- W1784018576 cites W2099549655 @default.
- W1784018576 cites W2119080350 @default.
- W1784018576 cites W2133926023 @default.
- W1784018576 cites W2137692886 @default.
- W1784018576 cites W2141093313 @default.
- W1784018576 cites W2148380143 @default.
- W1784018576 cites W2150028758 @default.
- W1784018576 cites W2166534380 @default.
- W1784018576 cites W2170999819 @default.
- W1784018576 cites W2254141218 @default.
- W1784018576 cites W2268923222 @default.
- W1784018576 cites W2322912881 @default.
- W1784018576 cites W4242069671 @default.
- W1784018576 doi "https://doi.org/10.31887/dcns.2004.6.3/akorczyn" @default.
- W1784018576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3181811" @default.
- W1784018576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22033779" @default.
- W1784018576 hasPublicationYear "2004" @default.
- W1784018576 type Work @default.
- W1784018576 sameAs 1784018576 @default.
- W1784018576 citedByCount "20" @default.
- W1784018576 countsByYear W17840185762017 @default.
- W1784018576 countsByYear W17840185762020 @default.
- W1784018576 countsByYear W17840185762021 @default.
- W1784018576 countsByYear W17840185762022 @default.
- W1784018576 countsByYear W17840185762023 @default.
- W1784018576 crossrefType "journal-article" @default.
- W1784018576 hasAuthorship W1784018576A5007494860 @default.
- W1784018576 hasBestOaLocation W17840185761 @default.
- W1784018576 hasConcept C118552586 @default.
- W1784018576 hasConcept C126322002 @default.
- W1784018576 hasConcept C137183658 @default.
- W1784018576 hasConcept C2776134090 @default.
- W1784018576 hasConcept C2776284327 @default.
- W1784018576 hasConcept C2776332859 @default.
- W1784018576 hasConcept C2776412080 @default.
- W1784018576 hasConcept C2776525014 @default.
- W1784018576 hasConcept C2777374534 @default.
- W1784018576 hasConcept C2778258207 @default.
- W1784018576 hasConcept C2778717949 @default.
- W1784018576 hasConcept C2779134260 @default.
- W1784018576 hasConcept C2779483572 @default.
- W1784018576 hasConcept C2779484449 @default.
- W1784018576 hasConcept C2779734285 @default.
- W1784018576 hasConcept C2780304432 @default.
- W1784018576 hasConcept C2780405171 @default.
- W1784018576 hasConcept C2780714222 @default.
- W1784018576 hasConcept C2780864610 @default.
- W1784018576 hasConcept C2780904820 @default.
- W1784018576 hasConcept C2781249495 @default.
- W1784018576 hasConcept C513476851 @default.
- W1784018576 hasConcept C71924100 @default.
- W1784018576 hasConcept C98274493 @default.
- W1784018576 hasConceptScore W1784018576C118552586 @default.
- W1784018576 hasConceptScore W1784018576C126322002 @default.
- W1784018576 hasConceptScore W1784018576C137183658 @default.
- W1784018576 hasConceptScore W1784018576C2776134090 @default.
- W1784018576 hasConceptScore W1784018576C2776284327 @default.
- W1784018576 hasConceptScore W1784018576C2776332859 @default.
- W1784018576 hasConceptScore W1784018576C2776412080 @default.
- W1784018576 hasConceptScore W1784018576C2776525014 @default.
- W1784018576 hasConceptScore W1784018576C2777374534 @default.
- W1784018576 hasConceptScore W1784018576C2778258207 @default.
- W1784018576 hasConceptScore W1784018576C2778717949 @default.
- W1784018576 hasConceptScore W1784018576C2779134260 @default.
- W1784018576 hasConceptScore W1784018576C2779483572 @default.
- W1784018576 hasConceptScore W1784018576C2779484449 @default.
- W1784018576 hasConceptScore W1784018576C2779734285 @default.
- W1784018576 hasConceptScore W1784018576C2780304432 @default.